Integer Holdings Corp shares climbed 20.3% in afternoon trading to $121.32, touching an intraday 52-week high of $123.50, after reports indicated that KKR is nearing a deal to take the company private at roughly $127 per share. Media accounts suggested a formal announcement could arrive as soon as next week.
The potential acquisition would be the end point of a strategic review that Integer's Board of Directors formally launched during the company’s first-quarter 2026 earnings call. The Board characterized that process as aimed at maximizing shareholder value. The review followed engagement by an activist investor and growing interest from private equity buyers attracted to Integer’s status as the only publicly traded contract development and manufacturing organization (CDMO) in the medical device space.
Integer’s position as a standalone, publicly listed medical-device CDMO is notable because that asset class has tended to command premium valuations in private markets. Analysts cited by the market have pointed toward comparable CDMO transactions completing in the mid-teens on an enterprise value-to-EBITDA basis, a level that implied material upside relative to where Integer had been trading prior to today’s move.
Research houses had already adjusted recommendations in light of Integer’s strategic review. Oppenheimer upgraded the stock to Outperform and set a $115 price target after the Board announced the review. KeyBanc kept an Overweight rating with a $104 target.
U.S. equity markets provided a supportive backdrop for risk assets on the day, with the S&P 500 up 0.75%, the Dow Jones Industrial Average rising 0.64%, and the Nasdaq Composite advancing 0.98%. Even so, Integer’s intraday spike far outpaced the broader market move, driven primarily by the buyout reports.
Market participants cited three elements that converged to produce the dramatic single-day gain: a concrete go-private bid at a meaningful premium to prevailing prices, a strategic review that had signaled the possibility of a transaction to investors, and a generally constructive macro environment for equities. Together, those factors pushed Integer to levels not seen in over a year and into the valuation range analysts had flagged as reasonable in a sale scenario.
Disclosure: The article reports on market developments and analyst coverage as described above.